Roche Pharma (Schweiz) AG
Roche Pharma (Schweiz) AG is a Originators company based in Basel (Basel-Stadt) recorded by Swissmedic as the authorisation holder for 53 human medicines. That places it 29 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Biotechnologika.
Key facts
| Sector | Originators |
|---|---|
| City | Basel |
| Canton | Basel-Stadt |
| Authorisation holder | Yes |
| Medicines | 53 |
| Founded | Not available |
| Employees | 201-1000 |
| Parent group | F. Hoffmann-La Roche AG |
| Activity | Not available |
| Website | roche.ch |
Medicines authorised in Switzerland
Roche Pharma (Schweiz) AG is recorded by Swissmedic as the authorisation holder for 53 human medicines. The table shows 48 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
48 of 53 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Actemra 162 mg/0.9 ml | 63166 | A | L04AC07 | 2014-09-12 |
| Actemra 162 mg/0.9 ml | 66931 | A | L04AC07 | 2018-12-10 |
| Actemra 80 mg/4 ml | 58868 | A | L04AC07 | 2008-12-02 |
| Alecensa 150 mg | 65970 | A | L01ED03 | 2017-01-26 |
| Avastin 100 mg/4 ml | 56922 | A | L01FG01 | 2004-12-16 |
| Cellcept | 54701 | B | L04AA06 | 1999-06-14 |
| Cellcept 250 mg | 53337 | B | L04AA06 | 1995-11-03 |
| Cellcept 500 mg | 53338 | B | L04AA06 | 1995-11-03 |
| Cellcept i.v. | 54688 | B | L04AA06 | 1998-08-31 |
| Columvi 2.5 mg/2.5 ml | 68297 | A | L01FX28 | 2023-11-07 |
| Cotellic 20mg | 65620 | A | L01EE02 | 2015-08-24 |
| Enspryng 120 mg | 67617 | A | L04AC19 | 2020-07-13 |
| Erivedge | 62497 | A | L01XJ01 | 2013-05-30 |
| Esbriet 267 mg | 66422 | B | L04AX05 | 2017-11-08 |
| Evrysdi 0.75 mg/ml | 67251 | A | M09AX10 | 2021-05-06 |
| Evrysdi 5 mg | 69919 | A | M09AX10 | 2025-05-27 |
| Gazyvaro 1000 mg/40 ml | 63172 | A | L01FA03 | 2014-06-10 |
| Hemlibra 30mg/1ml | 66694 | A | B02BX06 | 2018-11-06 |
| Herceptin 440 mg | 55065 | A | L01FD01 | 1999-07-29 |
| Herceptin subkutan 600mg/5ml | 65964 | A | L01FD01 | 2016-11-24 |
| Herclon 150 mg | 62748 | A | - | 2012-04-03 |
| Itovebi 3 mg | 69792 | A | L01EM06 | 2025-01-31 |
| Kadcyla 100 mg | 62892 | A | L01FD03 | 2013-05-02 |
| Lunsumio 1 mg/1 ml | 68314 | A | L01FX25 | 2023-02-09 |
| Lunsumio subkutan 5 mg/0.5ml | 70221 | A | L01FX25 | 2026-07-03 |
| MabThera 100 mg/10 ml | 54378 | A | L01FA01 | 1997-11-27 |
| MabThera subkutan 1400 mg/11.7 ml | 65813 | A | L01FA01 | 2016-06-28 |
| Madopar 250 | 43593 | B | N04BA02 | 1981-01-27 |
| Madopar 62.5 | 38096 | B | N04BA02 | 1973-06-27 |
| Madopar DR | 53493 | B | N04BA02 | 1996-10-29 |
| Madopar HBS | 48593 | B | - | 1987-06-18 |
| Madopar LIQ 62.5 | 52377 | B | N04BA02 | 1994-02-24 |
| Mircera 50 ug / 0.3 ml | 57860 | A | B03XA03 | 2007-09-27 |
| Ocrevus | 66185 | A | L04AG08 | 2017-09-20 |
| Ocrevus subkutan 920 mg/23 ml | 68988 | A | L04AG08 | 2024-11-15 |
| Perjeta 420 mg | 62510 | A | L01FD02 | 2012-08-13 |
| Phesgo 600 mg/600 mg/10 ml | 67828 | A | L01FY01 | 2021-04-08 |
| Piasky 340 mg/ 2 ml | 69340 | A | L04AJ07 | 2025-02-13 |
| Polivy 140 mg | 67165 | A | L01FX14 | 2021-06-15 |
| Pulmozyme | 52623 | B | R05CB13 | 1994-04-28 |
| Recormon PS 500 U.I./0 | 54766 | A | B03XA01 | 1998-09-29 |
| Ristova | 62757 | A | - | 2012-04-17 |
| Rocephin 250 mg i.m. | 44625 | A | J01DD04 | 1982-05-27 |
| Rozlytrek 100 mg | 67280 | A | L01EX14 | 2020-11-05 |
| Tamiflu 6 mg/ml | 56176 | B | J05AH02 | 2004-02-02 |
| Tamiflu 75 mg | 55196 | B | J05AH02 | 1999-09-21 |
| Tecentriq 1200 mg/20 ml | 66152 | A | L01FF05 | 2017-05-23 |
| TECENTRIQ subkutan 1875 mg/15ml | 69262 | A | L01FF05 | 2024-08-05 |
Frequently asked questions
How many medicines does Roche Pharma (Schweiz) AG have authorised in Switzerland?
Roche Pharma (Schweiz) AG is recorded by Swissmedic as the authorisation holder for 53 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Roche Pharma (Schweiz) AG based?
The Swiss location recorded for Roche Pharma (Schweiz) AG is Basel, Basel-Stadt.
Is Roche Pharma (Schweiz) AG a Swissmedic authorisation holder?
Yes. Roche Pharma (Schweiz) AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.